Sarah Boyce Insider Trading Transactions

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Sarah Boyce.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Sarah Boyce. Sarah Boyce is Director in LIGAND PHARMACEUTICALS INC ($LGND) and Chief Business Officer in IONIS PHARMACEUTICALS INC ($ISIS) and President and CEO in Avidity Biosciences, Inc. ($RNA) and President in AKCEA THERAPEUTICS, INC. ($AKCA) and Director in Berkeley Lights, Inc. ($BLI).

Latest Insider Trading Transactions of Sarah Boyce

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, AKCA, RNA, BLI, ISIS, LGND

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Jun 07 2021LGNDLIGAND PHARMACEUTI ...Boyce SarahDirectorOption ExerciseA115.393,269377,2103,269
Jun 07 2021LGNDLIGAND PHARMACEUTI ...Boyce SarahDirectorGrantA0.0063002,8922.3 K to 2.9 K (+27.85 %)
Jun 07 2021LGNDLIGAND PHARMACEUTI ...Boyce SarahDirectorOption ExerciseA115.393,269377,2103,269
Jun 07 2021LGNDLIGAND PHARMACEUTI ...Boyce SarahDirectorGrantA0.0063002,8922.3 K to 2.9 K (+27.85 %)
May 18 2021BLIBerkeley Lights, I ...Boyce SarahDirectorOption ExerciseA37.134,900181,9374,900
May 18 2021BLIBerkeley Lights, I ...Boyce SarahDirectorGrantA0.001,40001,4000 to 1.4 K
Mar 03 2021BLIBerkeley Lights, I ...Boyce SarahDirectorOption ExerciseM8.9010,00089,00090,000
Mar 03 2021BLIBerkeley Lights, I ...Boyce SarahDirectorSellS62.373,227201,27603.2 K to 0 (-100.00 %)
Mar 03 2021BLIBerkeley Lights, I ...Boyce SarahDirectorSellS61.133,000183,3883,2276.2 K to 3.2 K (-48.18 %)
Mar 03 2021BLIBerkeley Lights, I ...Boyce SarahDirectorSellS60.083,773226,6736,22710 K to 6.2 K (-37.73 %)
Mar 03 2021BLIBerkeley Lights, I ...Boyce SarahDirectorBuyM8.9010,00089,00010,0000 to 10 K
Feb 04 2021RNAAvidity Bioscience ...Boyce SarahPresident and CEOOption ExerciseA22.34300,0006,702,000300,000
Jun 12 2020LGNDLIGAND PHARMACEUTI ...Boyce SarahDirectorOption ExerciseA117.582,468290,1872,468
Jun 12 2020LGNDLIGAND PHARMACEUTI ...Boyce SarahDirectorGrantA0.0083102,2621.4 K to 2.3 K (+58.07 %)
Oct 16 2019LGNDLIGAND PHARMACEUTI ...Boyce SarahDirectorOption ExerciseA107.815,283569,5605,283
Oct 16 2019LGNDLIGAND PHARMACEUTI ...Boyce SarahDirectorGrantA0.001,43101,4310 to 1.4 K
Jul 17 2019AKCAAKCEA THERAPEUTICS ...Boyce SarahPresidentSellS23.521,81942,78319,88821.7 K to 19.9 K (-8.38 %)
Jul 03 2019AKCAAKCEA THERAPEUTICS ...Boyce SarahPresidentGrantA20.0481316,29521,70720.9 K to 21.7 K (+3.89 %)
Jan 04 2019AKCAAKCEA THERAPEUTICS ...Boyce SarahPresidentOption ExerciseA30.73173,0005,316,290173,000
Apr 18 2018AKCAAKCEA THERAPEUTICS ...Boyce SarahPresidentOption ExerciseA23.931,000,00023,930,0001,000,000
Apr 18 2018AKCAAKCEA THERAPEUTICS ...Boyce SarahPresidentGrantA0.0020,894020,8940 to 20.9 K
Jan 17 2018ISISIONIS PHARMACEUTIC ...Boyce SarahChief Business Offi ...Option ExerciseM0.005,367010,427
Jan 17 2018ISISIONIS PHARMACEUTIC ...Boyce SarahChief Business Offi ...Option ExerciseA0.0012,916012,916
Jan 17 2018ISISIONIS PHARMACEUTIC ...Boyce SarahChief Business Offi ...SellS51.762,196113,6658,93111.1 K to 8.9 K (-19.74 %)
Jan 17 2018ISISIONIS PHARMACEUTIC ...Boyce SarahChief Business Offi ...BuyM0.005,367011,1275.8 K to 11.1 K (+93.18 %)
Jan 02 2018ISISIONIS PHARMACEUTIC ...Boyce SarahChief Business Offi ...Option ExerciseA49.2558,1252,862,65658,125
Jan 02 2018ISISIONIS PHARMACEUTIC ...Boyce SarahChief Business Offi ...BuyJ42.7649120,9935,7605.3 K to 5.8 K (+9.32 %)
Jul 03 2017ISISIONIS PHARMACEUTIC ...Boyce SarahChief Business Offi ...BuyJ40.66176915,2695.3 K to 5.3 K (+0.32 %)
Jan 18 2017ISISIONIS PHARMACEUTIC ...Boyce SarahChief Business Offi ...Option ExerciseM0.001,29503,883
Jan 18 2017ISISIONIS PHARMACEUTIC ...Boyce SarahChief Business Offi ...Option ExerciseM0.002,18804,374
Jan 18 2017ISISIONIS PHARMACEUTIC ...Boyce SarahChief Business Offi ...Option ExerciseA0.007,53707,537
Jan 18 2017ISISIONIS PHARMACEUTIC ...Boyce SarahChief Business Offi ...SellS46.2950623,4235,2525.8 K to 5.3 K (-8.79 %)
Jan 18 2017ISISIONIS PHARMACEUTIC ...Boyce SarahChief Business Offi ...BuyM0.001,29505,7584.5 K to 5.8 K (+29.02 %)
Jan 18 2017ISISIONIS PHARMACEUTIC ...Boyce SarahChief Business Offi ...SellS46.2985539,5784,4635.3 K to 4.5 K (-16.08 %)
Jan 18 2017ISISIONIS PHARMACEUTIC ...Boyce SarahChief Business Offi ...BuyM0.002,18805,3183.1 K to 5.3 K (+69.90 %)
Jan 04 2017ISISIONIS PHARMACEUTIC ...Boyce SarahChief Business Offi ...Option ExerciseA47.3445,2252,140,95245,225
Jan 04 2017ISISIONIS PHARMACEUTIC ...Boyce SarahChief Business Offi ...BuyJ20.7699220,5913,1302.1 K to 3.1 K (+46.40 %)
Jul 01 2016ISISIONIS PHARMACEUTIC ...Boyce SarahChief Business Offi ...BuyJ20.764038,3652,1381.7 K to 2.1 K (+23.23 %)
Jan 19 2016ISISIONIS PHARMACEUTIC ...Boyce SarahChief Business Offi ...Option ExerciseM0.002,18806,562
Jan 19 2016ISISIONIS PHARMACEUTIC ...Boyce SarahChief Business Offi ...Option ExerciseA0.005,17805,178
Jan 19 2016ISISIONIS PHARMACEUTIC ...Boyce SarahChief Business Offi ...SellS41.4687236,1511,7352.6 K to 1.7 K (-33.45 %)
Jan 19 2016ISISIONIS PHARMACEUTIC ...Boyce SarahChief Business Offi ...BuyM0.002,18802,607419 to 2.6 K (+522.20 %)
Jan 04 2016ISISIONIS PHARMACEUTIC ...Boyce SarahChief Business Offi ...Option ExerciseA61.6831,0701,916,39831,070
Jan 04 2016ISISIONIS PHARMACEUTIC ...Boyce SarahChief Business Offi ...BuyJ47.7141919,9914190 to 419
Jan 20 2015ISISIONIS PHARMACEUTIC ...Boyce SarahChief Business Offi ...Option ExerciseA0.008,75008,750
Jan 05 2015ISISIONIS PHARMACEUTIC ...Boyce SarahChief Business Offi ...Option ExerciseA61.7452,5003,241,35052,500

Page:   1

Contact us | Follow us on Twitter